Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

2.

Radiation from CT scans could account for 5% of all cancer cases a year, study suggests

3.

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

4.

In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

5.

Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot